Findings point to molecular 'Achilles heel' for half of breast cancer tumors Researchers at Lombardi Comprehensive Cancer Center at Georgetown University Medical Center have shown why a protein known as cyclin D1 may be the Achilles heel for breast tumors that are estrogen receptor positive (ER+) − which is the most common type of breast cancer.
Source: EurekAlert Posted on:
Wednesday, Jan 16, 2008, 9:48am Views: 1212